BRIEF-Ascent Solar Technologies Announces Initial Closing Of Public Offering Of Common Stock, Pre-Funded Warrants-June 2024-www.financetom.com

BRIEF-Ascent Solar Technologies Announces Initial Closing Of Public Offering Of Common Stock, Pre-Funded Warrants

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Ascent Solar Technologies Announces Initial Closing Of Public Offering Of Common Stock, Pre-Funded Warrants

Apr 12, 2024 3:20 PM

April 12 (Reuters) - Ascent Solar Technologies Inc ( ASTI )

* ASCENT SOLAR TECHNOLOGIES, INC. ( ASTI ) ANNOUNCES INITIAL CLOSING

PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS

Source text for Eikon:

Further company coverage:

Previous page： AECOM Receives US Air Force Engineering, Support Contract Worth up to $1.5 Billion Next page： Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

AECOM Receives US Air Force Engineering, Support Contract Worth up to $1.5 Billion

Jun 4, 2025

08:26 AM EDT, 06/04/2025 (MT Newswires) -- AECOM ( ACM ) said Wednesday it has been selected by the US Air Force Civil Engineer Center to provide architecture and engineering services through a multiple-award task order contract with a $1.5 billion ceiling. The contract includes restoration, conservation, planning and environmental quality maintenance for the Air Force and other federal agencies,...

Sagimet's Partner Achieves Positive Results With Oral Acne Drug In Phase 3 Trial In China, Stock Jumps

Jun 4, 2025

Sagimet Biosciences Inc. ( SGMT ) said on Wednesday that denifanstat met all primary and secondary endpoints in a Phase 3 trial for moderate to severe acne vulgaris. The trial was conducted by Sagimet’s license partner, Ascletis Bioscience Co. Ltd., in China. Denifanstat is a once-daily oral small-molecule fatty acid synthase (FASN) inhibitor being developed by Ascletis as ASC40 for acne...

Thrive-backed accounting firm Crete to spend $500 million in AI roll-up

Jun 4, 2025

* Crete PA's revenue exceeds $300 million with 20 firms acquired * Thrive partners with OpenAI for customized accounting tools * Venture capital targets traditional services for AI-driven growth By Krystal Hu June 4 - Crete Professionals Alliance, an accounting platform backed by Thrive Capital, plans to invest over $500 million to acquire U.S.-based accounting firms in the next two...

RTX Unit Raytheon Wins $1.1 Billion US Navy Contract for AIM-9X Missile Production

Jun 4, 2025

08:32 AM EDT, 06/04/2025 (MT Newswires) -- RTX (RTX) said Wednesday that its Raytheon unit has been awarded a $1.1 billion contract from the US Navy to produce AIM-9X Block II missiles. The company said the contract will boost annual production to 2,500 missiles. The AIM-9X is an infrared-guided short-range missile that can be used in both air-to-air and surface-to-air...